When was NLC Health Ventures founded?

NLC Health Ventures was founded in 2014.

Where is NLC Health Ventures headquartered?

NLC Health Ventures is headquartered in Amsterdam, Netherlands.

What is NLC Health Ventures's total asset value?

NLC Health Ventures has around in total assets under management.

How many investments has NLC Health Ventures made?

NLC Health Ventures has made 226 investments.

What has NLC Health Ventures invested in?

NLC Health Ventures has made numerous investments in companies like Ansana , Thalia Therapeutics , and Sanmirna Therapeutics within the Healthcare Technology Systems and Drug Discovery industries.

What has NLC Health Ventures invested in recently?

NLC Health Ventures's latest investment was on 01-Jan-2027 in Ansana , a company within the Healthcare Technology Systems industry.

NLC Health Ventures investment portfolio

NLC Health Ventures Overview

Investor Type

Venture Capital

Status

Active

Professionals

17

Investments

226

Portfolio

78

Exits

40

NLC Health Ventures General Information

Company Description

Founded in 2014, NLC is a venture capital firm based in Amsterdam, Netherlands. The firm seeks to invest in healthtech, biotech, medtech, digital health, and green health sectors. The firm operates as a venture builder and early-stage investor, co-founding companies from scientific invention through to clinical deployment.

Business Details

Website

www.nlc.health

Year Founded

2014

Investor Status

Actively Seeking New Investments

Trade Association

Dutch Venture Capital Association (NVP)

Primary Investor Type

Venture Capital

Other Investor Types

Accelerator/Incubator

Impact Investing

Corporate Office

Meester Treublaan
1097 DP Amsterdam
Netherlands

+31 020







NLC Health Ventures Investments (226)

Company Name	Deal Date	Deal Type	Industry	Company Stage
Ansana	01-Jan-2027	Early Stage VC	Other Healthcare Technology Systems	Product Development
Thalia Therapeutics	20-Jul-2026		Drug Discovery	Generating Revenue
Sanmirna Therapeutics	24-Jun-2026		Drug Discovery	Pre-Clinical Trials
Garland Surgical	05-Feb-2026		Therapeutic Devices	Product Development
Sigilla Medical	01-Feb-2026		Surgical Devices	Pre-Clinical Trials
Respiosa	28-Nov-2025		Surgical Devices	Startup
Concord Neonatal	14-Nov-2025		Surgical Devices	Generating Revenue
Implant Preservation Devices	06-Nov-2025		Surgical Devices	Clinical Trials - Phase 1
OccluNova	06-Nov-2025	Seed Round	Therapeutic Devices	Clinical Trials - Phase 3
Liftya (Therapeutic Devices)	01-Nov-2025	Seed Round	Therapeutic Devices	Generating Revenue

You’re viewing 10 of 226 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NLC Health Ventures Exits (40)

Company Name	Exit Date	Exit Type
RICE Pharmaceuticals	29-Oct-2026	Out of Business
Heat2Move	14-Aug-2026
SERDA Therapeutics	16-Jul-2026
ImplantGuard	30-Jun-2026
FlowView Diagnostics	13-Jun-2026
IntercepTx	23-May-2026
NeurOdys Therapeutics	28-Apr-2026
Capnosway	26-Apr-2026
ARNE	17-Mar-2026	Bankruptcy: Liquidation
Ecomedic	13-Mar-2026	Out of Business

You’re viewing 10 of 40 exits. Get the full list »

NLC Health Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.